Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of f (Q71197308)
Jump to navigation
Jump to search
scientific article published on 01 July 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of f |
scientific article published on 01 July 1996 |
Statements
Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil (English)
B Fisher
J Dignam
E P Mamounas
J P Costantino
D L Wickerham
C Redmond
N Wolmark
N V Dimitrov
D M Bowman
A G Glass
J N Atkins
N Abramson
C M Sutherland
B S Aron
R G Margolese